Huawei is looking to bring ECG, non-invasive blood sugar and blood pressure capabilities to future Watch GT smartwatches
Huawei is supposedly due to release new Watch GT smartwatches this year, having stuck with its second generation for over eighteen months. While we liked the Watch GT 2 Pro when we reviewed it, its competitors have more health functions. For example, Apple and Samsung's recent efforts can measure blood pressure and can take ECGs. By contrast, the Huawei Watch GT 2 Pro can do neither of these.
However, that could change with future Watch GT generations. According to ITHome, Huawei is developing new sensors to enable continuous ECG and blood pressure measurements. If the company pulls this off, then it may be able to release smartwatches that can read these values in the background, something that is not possible with conventional smartwatches currently.
Huawei hopes to bring non-invasive blood glucose measurement technologies to market too, an innovation that could simplify life for diabetics. ITHome reports that this sensor should be able to record blood sugar levels in the background, too. Unfortunately, Huawei has not provided a timescale for when it will put these sensors into mass production. Incidentally, Apple reportedly has a team focused on developing non-invasive and continuous glucose monitoring, so we may not be too far away from a smartwatch with that functionality being commercially available.
Source(s)
